Drucker Wealth 3.0 LLC Grows Holdings in Bath & Body Works, Inc. $BBWI

Drucker Wealth 3.0 LLC raised its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 133.5% in the 1st quarter, Holdings Channel reports. The firm owned 52,857 shares of the company’s stock after purchasing an additional 30,217 shares during the quarter. Drucker Wealth 3.0 LLC’s holdings in Bath & Body Works were worth $987,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Royal Bank of Canada lifted its holdings in Bath & Body Works by 92.8% during the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after buying an additional 28,815 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock worth $19,586,000 after acquiring an additional 87,529 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Bath & Body Works by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock worth $17,063,000 after acquiring an additional 36,684 shares during the period. Intech Investment Management LLC purchased a new position in shares of Bath & Body Works during the first quarter worth approximately $1,155,000. Finally, Geneos Wealth Management Inc. raised its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

Shares of BBWI opened at $23.51 on Tuesday. The company has a 50 day moving average price of $19.25 and a 200-day moving average price of $20.32. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $33.96. The stock has a market capitalization of $4.74 billion, a PE ratio of 6.61, a PEG ratio of 2.27 and a beta of 1.42.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. Bath & Body Works’s revenue was down 3.2% compared to the same quarter last year. During the same period last year, the company posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts forecast that Bath & Body Works, Inc. will post 2.62 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were issued a $0.20 dividend. The ex-dividend date was Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.4%. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on BBWI. Piper Sandler started coverage on Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. Barclays reduced their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a report on Thursday, May 28th. Weiss Ratings cut Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, June 2nd. Wells Fargo & Company increased their price target on Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 23rd. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Tuesday, March 3rd. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $22.00.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.